The serine protease inhibitor serpinE2 is a novel target of ERK signaling involved in human colorectal tumorigenesis

Sébastien Bergeron(Université de Sherbrooke), Nathalie Rivard(Université de Sherbrooke)
Molecular Cancer
October 13, 2010
Cited by 92


Related Papers